China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Severe bilateral corneal epitheliopathy after the first treatment cycle of trastuzumab botidotin: a case report'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133382
Registration Time: 2026/09/24
Type: Observational study
Primary Sponsor: The Fifth Affiliated Hospital, Sun Yat-Sen University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345258
Published by HT Digital Content Services with permission from Health Daily Digest....